Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how CorVel Corporation converts advanced analytics into lower claim costs is vital, yet the company’s SEC paperwork is a maze of healthcare billing codes, captive insurance structures, and network contracting jargon. If you have ever searched “What does CorVel report in its 10-K?” or tried to locate a single footnote on network revenue in a 300-page filing, you know the challenge. Stock Titan resolves that frustration by layering AI-driven language models on top of every disclosure, turning raw documents into plain-English takeaways you can scan in seconds.
Open the CorVel annual report 10-K simplified to see segment profitability, risk factors, and how the CareMC platform scales. Need the latest CorVel quarterly earnings report 10-Q filing? We post it within minutes of hitting EDGAR and attach side-by-side KPI trends. Material updates, such as new managed-care contracts or Medicare set-aside rulings, appear under CorVel 8-K material events explained. Our dashboard also streams CorVel insider trading Form 4 transactions and CorVel executive stock transactions Form 4 so you can watch ownership shifts in real time and cross-check details in the CorVel proxy statement executive compensation section.
Whether you’re benchmarking medical cost containment peers or simply want CorVel SEC filings explained simply, Stock Titan’s tools help you:
- Spot margin shifts with CorVel earnings report filing analysis.
- Receive CorVel Form 4 insider transactions real-time on any device.
- Compare claim volume trends across regions without reading every exhibit.
- Understand complex reimbursement tables with AI-powered summaries.
All filings update automatically, and every paragraph links back to the source so analysts, insurers, and portfolio managers can trust the detail while saving hours. Understanding CorVel SEC documents with AI no longer requires a legal background—just open the page and let the insights surface.
Credo Technology Group Holding Ltd (CRDO) – Form 144 filing
Walden Technology Ventures II LP has filed a Notice of Proposed Sale of Securities under Rule 144. The fund intends to sell 12,248 common shares of Credo Technology through Morgan Stanley Smith Barney, with an aggregate market value of US $1.14 million. The anticipated sale date is 25 June 2025 on the NASDAQ exchange. Credo’s total shares outstanding are listed at 169,801,216, making the proposed sale approximately 0.007 % of shares outstanding.
The filing also discloses seven prior sales over the past three months by the same limited partnership, totaling 484,297 shares and US $42.2 million in gross proceeds. Individual transactions ranged from 3,527 to 171,473 shares, with sale dates between 5 June 2025 and 24 June 2025.
No adverse information about Credo’s operations is referenced in the filing, and the seller affirms it is not in possession of undisclosed material information. The shares were originally acquired on 22 December 2020 via a private transaction with the issuer and were paid for in cash.
Key Takeaways:
- Additional planned insider sale follows a series of sizable recent disposals.
- Cumulative sales by Walden in the last quarter represent about 0.29 % of Credo’s shares outstanding.
- While individually small, continued selling may create a perception of supply overhang among investors.
CorVel Corporation (CRVL) has filed its definitive 2025 proxy statement (DEF 14A) ahead of the Annual Meeting scheduled for Thursday, August 7, 2025, at 8:30 a.m. PT in Milwaukie, Oregon. The Board has fixed June 13, 2025, as the record date; 51,440,930 common shares are entitled to vote.
Key proposals:
- Proposal 1 – Election of six directors: Michael G. Combs, Joanna C. Burkey, Steven J. Hamerslag, Alan R. Hoops, R. Judd Jessup and Jeffrey J. Michael. Five of six nominees are classified as independent, and several hold committee assignments across Audit, Nomination & Governance, and Compensation.
- Proposal 2 – Auditor ratification: Haskell & White LLP re-appointed as independent registered public accounting firm for the fiscal year ending March 31, 2026.
- Proposal 3 – 2025 Stock Incentive Plan: seeks shareholder approval of a new equity plan designed to align management incentives with shareholder interests.
The Board unanimously recommends “FOR ALL” director nominees and “FOR” Proposals 2 and 3. No other business is currently expected.
Voting options include Internet, toll-free telephone, mail, or in-person ballot. Internet and phone voting close at 11:59 p.m. ET on August 6, 2025.
This filing is routine but confirms corporate governance continuity, auditor oversight, and refreshes the company’s equity-based compensation program.
FAQ
What is the current stock price of Corvel (CRVL)?
What is the market cap of Corvel (CRVL)?
What is CorVel Corp's primary business focus?
How does CorVel integrate technology into its services?
Who are the main clients of CorVel Corp?
What range of services does CorVel offer?
How does CorVel ensure the quality and security of its services?
In what ways does CorVel differentiate itself from competitors?
What role does AI play in CorVel's operations?
How does CorVel maintain its operational excellence?
